Description:
SOMAÍ Pharmaceuticals Australia is an Australian subsidiary of a leading EU-GMP European pharmaceutical and biotech company, SOMAÍ Group, with a global footprint of distribution for the largest and most advanced EU GMP-certified cannabinoid-containing pharmaceuticals portfolio.
At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine.
For more information, please contact us with the following details:
Contact Email:
.png){kind=logo}
.png){kind=logo}
Our Network
